Sichuan Kelun Pharmaceutical Co., Ltd.

SZSE:002422 Stock Report

Market Cap: CN¥47.4b

Sichuan Kelun Pharmaceutical Balance Sheet Health

Financial Health criteria checks 6/6

Sichuan Kelun Pharmaceutical has a total shareholder equity of CN¥26.2B and total debt of CN¥5.2B, which brings its debt-to-equity ratio to 19.7%. Its total assets and total liabilities are CN¥38.4B and CN¥12.2B respectively. Sichuan Kelun Pharmaceutical's EBIT is CN¥4.3B making its interest coverage ratio -40.6. It has cash and short-term investments of CN¥7.1B.

Key information

19.7%

Debt to equity ratio

CN¥5.16b

Debt

Interest coverage ratio-40.6x
CashCN¥7.08b
EquityCN¥26.23b
Total liabilitiesCN¥12.16b
Total assetsCN¥38.39b

Recent financial health updates

Recent updates

Here's Why Sichuan Kelun Pharmaceutical (SZSE:002422) Has Caught The Eye Of Investors

Nov 17
Here's Why Sichuan Kelun Pharmaceutical (SZSE:002422) Has Caught The Eye Of Investors

Sichuan Kelun Pharmaceutical (SZSE:002422) Has A Rock Solid Balance Sheet

Oct 28
Sichuan Kelun Pharmaceutical (SZSE:002422) Has A Rock Solid Balance Sheet

Sichuan Kelun Pharmaceutical Co., Ltd.'s (SZSE:002422) Low P/E No Reason For Excitement

Sep 22
Sichuan Kelun Pharmaceutical Co., Ltd.'s (SZSE:002422) Low P/E No Reason For Excitement

Should You Be Adding Sichuan Kelun Pharmaceutical (SZSE:002422) To Your Watchlist Today?

Aug 16
Should You Be Adding Sichuan Kelun Pharmaceutical (SZSE:002422) To Your Watchlist Today?

Is Sichuan Kelun Pharmaceutical (SZSE:002422) Using Too Much Debt?

Jul 12
Is Sichuan Kelun Pharmaceutical (SZSE:002422) Using Too Much Debt?

Sichuan Kelun Pharmaceutical Co., Ltd.'s (SZSE:002422) Prospects Need A Boost To Lift Shares

Jun 11
Sichuan Kelun Pharmaceutical Co., Ltd.'s (SZSE:002422) Prospects Need A Boost To Lift Shares

An Intrinsic Calculation For Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) Suggests It's 45% Undervalued

May 21
An Intrinsic Calculation For Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) Suggests It's 45% Undervalued

Sichuan Kelun Pharmaceutical's (SZSE:002422) Earnings Are Weaker Than They Seem

May 02
Sichuan Kelun Pharmaceutical's (SZSE:002422) Earnings Are Weaker Than They Seem

If EPS Growth Is Important To You, Sichuan Kelun Pharmaceutical (SZSE:002422) Presents An Opportunity

Mar 19
If EPS Growth Is Important To You, Sichuan Kelun Pharmaceutical (SZSE:002422) Presents An Opportunity

Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) Surges 25% Yet Its Low P/E Is No Reason For Excitement

Mar 04
Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) Surges 25% Yet Its Low P/E Is No Reason For Excitement

These 4 Measures Indicate That Sichuan Kelun Pharmaceutical (SZSE:002422) Is Using Debt Safely

Feb 27
These 4 Measures Indicate That Sichuan Kelun Pharmaceutical (SZSE:002422) Is Using Debt Safely

Financial Position Analysis

Short Term Liabilities: 002422's short term assets (CN¥19.1B) exceed its short term liabilities (CN¥10.1B).

Long Term Liabilities: 002422's short term assets (CN¥19.1B) exceed its long term liabilities (CN¥2.0B).


Debt to Equity History and Analysis

Debt Level: 002422 has more cash than its total debt.

Reducing Debt: 002422's debt to equity ratio has reduced from 78% to 19.7% over the past 5 years.

Debt Coverage: 002422's debt is well covered by operating cash flow (84.6%).

Interest Coverage: 002422 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies